COGENT NEUROSCIENCE Trademark

Trademark Overview


On Friday, May 5, 2000, a trademark application was filed for COGENT NEUROSCIENCE with the United States Patent and Trademark Office. The USPTO has given the COGENT NEUROSCIENCE trademark a serial number of 76042671. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, December 19, 2002. This trademark is owned by Cogent Neuroscience, Inc.. The COGENT NEUROSCIENCE trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Biochemicals for use in the field of genetic pharmacology, namely, genetic materials for the manufacture, research and development of gene and cell therapy and diagnostic products for various neurological conditions and diseases

Scientific research, analysis, testing, evaluation and consultation in the field of genomics and biotechnology; Genomic research, namely genetic mapping of genetic and neurological diseases, performing functional assays of genes and sequencing genes; patent technology licensing services in the field of pharmaceuticals, biologics and gene therapy
cogent neuroscience

General Information


Serial Number76042671
Word MarkCOGENT NEUROSCIENCE
Filing DateFriday, May 5, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, December 19, 2002
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 10, 2001

Trademark Statements


Disclaimer with Predetermined Text"NEUROSCIENCE"
Goods and ServicesBiochemicals for use in the field of genetic pharmacology, namely, genetic materials for the manufacture, research and development of gene and cell therapy and diagnostic products for various neurological conditions and diseases
Goods and ServicesScientific research, analysis, testing, evaluation and consultation in the field of genomics and biotechnology; Genomic research, namely genetic mapping of genetic and neurological diseases, performing functional assays of genes and sequencing genes; patent technology licensing services in the field of pharmaceuticals, biologics and gene therapy

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, July 20, 2000
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 20, 2000
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCogent Neuroscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27701

Party NameCogent Neuroscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27701

Trademark Events


Event DateEvent Description
Sunday, May 18, 2003ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 18, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 26, 2001NOTICE OF ALLOWANCE CANCELLED
Tuesday, July 3, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2001PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2001NOTICE OF PUBLICATION
Tuesday, December 12, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2000EXAMINER'S AMENDMENT MAILED
Tuesday, October 3, 2000NON-FINAL ACTION MAILED
Wednesday, September 27, 2000ASSIGNED TO EXAMINER